Absci (ABSI) Other Non-Current Assets (2021 - 2026)
Absci (ABSI) posted Other Non-Current Assets of $1.1 million for Q1 2026, up 0.85% sequentially from $1.1 million in Q4 2025, and up 68.3% YoY from $631000.0 in Q1 2025.
Absci (ABSI) Other Non-Current Assets (2021 - 2026) Analysis & Trends
Absci has reported Other Non-Current Assets for 6 years, with the latest figure at $1.1 million in Q1 2026.
- Quarterly Other Non-Current Assets rose 68.3% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (up 68.3% YoY) and the FY2025 annual result came in at $1.1 million, down 93.4% from the prior year.
- Other Non-Current Assets grew to $1.1 million in Q1 2026 per ABSI's latest filing, from $1.1 million in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $16.5 million in Q2 2024 and troughed at $631000.0 in Q1 2025.
- A 5-year average of $4.8 million and a median of $1.6 million in 2024 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets surged 937.54% in 2024, then tumbled 95.66% in 2025.
- Over 5 years, Other Non-Current Assets stood at $1.9 million in 2022, then fell by 17.54% to $1.5 million in 2023, then soared by 937.54% to $15.9 million in 2024, then slumped by 93.4% to $1.1 million in 2025, then advanced by 0.85% to $1.1 million in 2026.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $1.1 million, $1.1 million, and $16.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 124.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 42.45 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 109.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 18,237.65 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 62.96 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 65.13 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 104.44 Mn |
| 10 | Absci | 1.58 Bn | 1.37 Bn | - | 1.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.05 Mn |
| Mar 31, 2026 | 1.06 Mn |
| Dec 31, 2025 | 1.05 Mn |
| Sep 30, 2025 | 16.34 Mn |
| Jun 30, 2025 | 716,000.00 |
| Mar 31, 2025 | 631,000.00 |
| Dec 31, 2024 | 15.95 Mn |
| Sep 30, 2024 | 1.61 Mn |
| Jun 30, 2024 | 16.51 Mn |
| Mar 31, 2024 | 1.53 Mn |
| Dec 31, 2023 | 1.54 Mn |
| Sep 30, 2023 | 1.54 Mn |
| Jun 30, 2023 | 15.07 Mn |
| Mar 31, 2023 | 1.88 Mn |
| Dec 31, 2022 | 1.86 Mn |
| Sep 30, 2022 | 1.29 Mn |
| Jun 30, 2022 | 1.85 Mn |
| Mar 31, 2022 | 1.84 Mn |
| Dec 31, 2021 | 1.29 Mn |
| Sep 30, 2021 | 10.51 Mn |